Sarcoma  >>  Aurimune (CYT-6091)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Aurimune (CYT-6091) / CytImmune
NCT00436410: Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Completed
1
108
US
colloidal gold-bound tumor necrosis factor, electron microscopy, pharmacological study, conventional surgery
National Institutes of Health Clinical Center (CC), National Cancer Institute (NCI)
Adrenocortical Carcinoma, Breast Cancer, Colorectal Cancer, Gastrointestinal Cancer, Kidney Cancer, Liver Cancer, Melanoma (Skin), Ovarian Cancer, Pancreatic Cancer, Sarcoma
 
08/09

Download Options